Skip to content

Effects of Lead Exposure on Ferroptosis Pathway

Effects of Lead Exposure on Iron Metabolism and the Nrf2-dependent Ferroptosis Pathway

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05950386
Enrollment
40
Registered
2023-07-18
Start date
2023-07-01
Completion date
2023-09-25
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lead Poisoning, Neurotoxicity

Keywords

Ferroptosis, Nrf2, Iron metabolism, Lead exposure, Neurotoxicity

Brief summary

The aim of this study was to investigate the effects of chronic lead exposure on iron metabolism and the Nrf2-dependent ferroptosis pathway in lead acid battery factory workers

Detailed description

Background: Lead (Pb) is a prevalent and highly toxic heavy metal. Human activities have been the primary cause of lead contamination in the environment over the past century. Lead exposure poses a global concern, particularly for children, and individuals can be exposed to lead through various means, such as contaminated soil, dust, food, water, or foreign objects. The central nervous system (CNS) is particularly vulnerable to the toxic effects of lead (Pb), especially in children, primarily due to the immaturity of the blood-brain barrier. Ferroptosis is a recently defined form of regulated cell death characterized by iron-dependent cell death resulting from the accumulation of lipid hydroperoxides. However, the exact mechanism underlying the neurotoxic effects of chronic low-level lead exposure-induced ferroptosis on neuronal injury is not yet fully understood. Methods: The investigators first analyze the difference of blood lead level using atomic absorption spectrometry. The investigators enrolled 20 chronic lead exposure workers from a lead acid battery factory and an age-matched control group of non-lead-exposed workers. TNF-α elisa kit was used to compare the proinflammatory cytokines in two groups. Quantitative reverse transcription PCR (Polymerase Chain Reaction) was used to compare messenger ribonucleic acid (mRNA) expression of iron metabolism (FTH1, FPN1, DMT1) and the Nrf2-dependent ferroptosis pathway (Nrf2, SLC7A11, GPX4) Detailed Methods protocol 1. The criteria of enrolled chronic lead exposure participants were as follows:inclusion: work for this lead acid battery factory more than 10 year; exclusion: exposure to any chemistry pollution before; neurological disorders; endocrine diseases; cancer 2. Sample collection: at the end of recruitment in this study, all of the enrolled participant will come to the hospital to collect peripheral Blood (Northern Jiangsu People's Hospital, affiliated with Yangzhou University), and the blood samples will be collected into EDTA (ethyleneDiamine tetraacetic acid) vacutainer tubes and then divided into leukocytes and plasma for further experiments. 3. TNF-α ELISA KIT: Plasma TNF-α concentrations were detected by the competitive ELISA method 4. Primer sequence used in this study: 1.DMT1 forward: 5'-CTAGACTGGGAGTGGTTACTGG-3' DMT1 reverse: 5'-AGGATGACTCGTGGGACCTT-3' 2.FTH1 forward: 5'-CTGGTGGCCGAATCTTCCTTCA-3' FTH1 reverse: 5'-GCCAGTTTGTGCAGTTCCAG-3' 3.FPN1 forward: 5'-CTACTTGGGGAGATCGGATGT-3' FPN1 reverse: 5'-CTGGGCCACTTTAAGTCTAGC-3' 4.GPX4 forward: 5'-GAGGCAAGACCGAAGTAAACTAC-3' GPX4 reverse: 5'-CCGAACTGGTTACACGGGAA-3' 5.SLC7A11 forward: 5'-TCTCCAAAGGAGGTTACCTGC-3' SLC7A11 reverse: 5'-AGACTCCCCTCAGTAAAGTGAC-3' 6. Nrf2 forward 5'-ATAGCTGAGCCCAGTATC-3' Nrf2 reverse 5'- CATGCACGTGAGTGCTCT-3' 7. GAPDH forward: 5'-GGAGCGAGATCCCTCCAAAAT-3' GAPDH reverse: 5'-GGCTGTTGTCATACTTCTCATGG-3'

Interventions

OTHERLead exposure

The lead-acid battery factory workers will exposure to lead via Inhalation of lead particles, ingestion of lead-contaminated dust and water.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Northern Jiangsu People's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Aged over 18 years old 2. Work for the lead acid battery factory more than 10 years

Exclusion criteria

1. Neurological disorders 2. Endocrine diseases 3. Cancer 4. Exposure to any chemical pollutant before

Design outcomes

Primary

MeasureTime frameDescription
Concentration of TNF-α level in peripheral bloodFrom the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 60 daysBiomarkers of the proinflammatory cytokines
The relative mRNA expression rate of the Nrf2- dependent ferroptosis genes in peripheral bloodFrom the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 60 daysBiomarkers of the Nrf2- dependent ferroptosis
The relative mRNA expression rate of the iron metabolism genes in peripheral bloodFrom the date of all participants documented baseline data, until the date of the last participant documented the changes of biomarkers in peripheral blood, assessed up to 60 daysBiomarkers of the iron metabolism

Countries

China

Contacts

Primary ContactJu Gao
gaoju_003@163.com+8618118206088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026